Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 22

1.

Low density lipoprotein receptor-related protein 5 gene polymorphisms and osteoporosis in Thai menopausal women.

Kitjaroentham A, Hananantachai H, Phonrat B, Preutthipan S, Tungtrongchitr R.

J Negat Results Biomed. 2016 Sep 1;15(1):16. doi: 10.1186/s12952-016-0059-7.

2.

Runx2/DICER/miRNA Pathway in Regulating Osteogenesis.

Zheng L, Tu Q, Meng S, Zhang L, Yu L, Song J, Hu Y, Sui L, Zhang J, Dard M, Cheng J, Murray D, Tang Y, Lian JB, Stein GS, Chen J.

J Cell Physiol. 2017 Jan;232(1):182-91. doi: 10.1002/jcp.25406. Epub 2016 Apr 26.

PMID:
27064596
3.

Osteoporosis-Pseudoglioma in a Mauritanian Child due to a Novel Mutation in LRP5.

Biha N, Ghaber SM, Hacen MM, Collet C.

Case Rep Genet. 2016;2016:9814928. doi: 10.1155/2016/9814928. Epub 2016 Jan 19.

4.
5.

Chondrocyte β-catenin signaling regulates postnatal bone remodeling through modulation of osteoclast formation in a murine model.

Wang B, Jin H, Zhu M, Li J, Zhao L, Zhang Y, Tang D, Xiao G, Xing L, Boyce BF, Chen D.

Arthritis Rheumatol. 2014 Jan;66(1):107-20. doi: 10.1002/art.38195. Erratum in: Arthritis Rheumatol. 2015 Sep;67(9):2465.

6.

Occupational and genetic risk factors for osteoarthritis: a review.

Yucesoy B, Charles LE, Baker B, Burchfiel CM.

Work. 2015 Jan 1;50(2):261-73. doi: 10.3233/WOR-131739. Review.

7.

Wnt signaling in bone.

Kubota T, Michigami T, Ozono K.

Clin Pediatr Endocrinol. 2010 Jul;19(3):49-56. doi: 10.1297/cpe.19.49. Epub 2010 Aug 31.

8.

Inactivation of Lrp5 in osteocytes reduces young's modulus and responsiveness to the mechanical loading.

Zhao L, Shim JW, Dodge TR, Robling AG, Yokota H.

Bone. 2013 May;54(1):35-43. doi: 10.1016/j.bone.2013.01.033. Epub 2013 Jan 26.

9.

Rapid-throughput skeletal phenotyping of 100 knockout mice identifies 9 new genes that determine bone strength.

Bassett JH, Gogakos A, White JK, Evans H, Jacques RM, van der Spek AH; Sanger Mouse Genetics Project, Ramirez-Solis R, Ryder E, Sunter D, Boyde A, Campbell MJ, Croucher PI, Williams GR.

PLoS Genet. 2012;8(8):e1002858. doi: 10.1371/journal.pgen.1002858. Epub 2012 Aug 2.

10.

Dissecting molecular differences between Wnt coreceptors LRP5 and LRP6.

MacDonald BT, Semenov MV, Huang H, He X.

PLoS One. 2011;6(8):e23537. doi: 10.1371/journal.pone.0023537. Epub 2011 Aug 24.

11.

Identification of the first deletion in the LRP5 gene in a patient with autosomal dominant osteopetrosis type I.

Pangrazio A, Boudin E, Piters E, Damante G, Lo Iacono N, D'Elia AV, Vezzoni P, Van Hul W, Villa A, Sobacchi C.

Bone. 2011 Sep;49(3):568-71. doi: 10.1016/j.bone.2011.05.006. Epub 2011 May 11.

12.

Bone overgrowth-associated mutations in the LRP4 gene impair sclerostin facilitator function.

Leupin O, Piters E, Halleux C, Hu S, Kramer I, Morvan F, Bouwmeester T, Schirle M, Bueno-Lozano M, Fuentes FJ, Itin PH, Boudin E, de Freitas F, Jennes K, Brannetti B, Charara N, Ebersbach H, Geisse S, Lu CX, Bauer A, Van Hul W, Kneissel M.

J Biol Chem. 2011 Jun 3;286(22):19489-500. doi: 10.1074/jbc.M110.190330. Epub 2011 Apr 6.

13.

Effects of miR-335-5p in modulating osteogenic differentiation by specifically downregulating Wnt antagonist DKK1.

Zhang J, Tu Q, Bonewald LF, He X, Stein G, Lian J, Chen J.

J Bone Miner Res. 2011 Aug;26(8):1953-63. doi: 10.1002/jbmr.377.

14.

LRP5 gene polymorphism and cortical bone.

Lauretani F, Cepollaro C, Bandinelli S, Cherubini A, Gozzini A, Masi L, Falchetti A, Del Monte F, Carbonell-Sala S, Marini F, Tanini A, Corsi AM, Ceda GP, Brandi ML, Ferrucci L.

Aging Clin Exp Res. 2010 Aug;22(4):281-8.

15.

WISP-1/CCN4 regulates osteogenesis by enhancing BMP-2 activity.

Ono M, Inkson CA, Kilts TM, Young MF.

J Bone Miner Res. 2011 Jan;26(1):193-208. doi: 10.1002/jbmr.205.

16.

Osteosclerosis owing to Notch gain of function is solely Rbpj-dependent.

Tao J, Chen S, Yang T, Dawson B, Munivez E, Bertin T, Lee B.

J Bone Miner Res. 2010 Oct;25(10):2175-83. doi: 10.1002/jbmr.115.

17.

N-cadherin negatively regulates osteoblast proliferation and survival by antagonizing Wnt, ERK and PI3K/Akt signalling.

Haÿ E, Nouraud A, Marie PJ.

PLoS One. 2009 Dec 14;4(12):e8284. doi: 10.1371/journal.pone.0008284.

18.

Lrp4, a novel receptor for Dickkopf 1 and sclerostin, is expressed by osteoblasts and regulates bone growth and turnover in vivo.

Choi HY, Dieckmann M, Herz J, Niemeier A.

PLoS One. 2009 Nov 20;4(11):e7930. doi: 10.1371/journal.pone.0007930.

19.

Non-association between polymorphisms of the frizzled receptor genes and bone mineral density in postmenopausal Korean women.

Kim JG, Kim H, Jee BC, Suh CS, Choi YM, Moon SY.

J Korean Med Sci. 2009 Jun;24(3):443-7. doi: 10.3346/jkms.2009.24.3.443. Epub 2009 Jun 12.

20.

Wnt inhibitory factor 1 is epigenetically silenced in human osteosarcoma, and targeted disruption accelerates osteosarcomagenesis in mice.

Kansara M, Tsang M, Kodjabachian L, Sims NA, Trivett MK, Ehrich M, Dobrovic A, Slavin J, Choong PF, Simmons PJ, Dawid IB, Thomas DM.

J Clin Invest. 2009 Apr;119(4):837-51. doi: 10.1172/JCI37175. Epub 2009 Mar 23.

Supplemental Content

Support Center